BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19274671)

  • 21. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke.
    Georgiadis P; Demopoulos NA; Topinka J; Stephanou G; Stoikidou M; Bekyrou M; Katsouyianni K; Sram R; Autrup H; Kyrtopoulos SA
    Toxicol Lett; 2004 Apr; 149(1-3):269-80. PubMed ID: 15093273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolism of 4-aminobiphenyl in rat. II. Reaction of N-hydroxy-4-aminobiphenyl with rat blood in vitro.
    Heilmair R; Karreth S; Lenk W
    Xenobiotica; 1991 Jun; 21(6):805-15. PubMed ID: 1949910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of Hemoglobin and White Blood Cell DNA Adducts of the Tobacco Carcinogens 2-Amino-9H-pyrido[2,3-b]indole and 4-Aminobiphenyl Formed in Humans by Nanoflow Liquid Chromatography/Ion Trap Multistage Mass Spectrometry.
    Cai T; Bellamri M; Ming X; Koh WP; Yu MC; Turesky RJ
    Chem Res Toxicol; 2017 Jun; 30(6):1333-1343. PubMed ID: 28493705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
    Airoldi L; Vineis P; Colombi A; Olgiati L; Dell'Osta C; Fanelli R; Manzi L; Veglia F; Autrup H; Dunning A; Garte S; Hainaut P; Hoek G; Krzyzanowski M; Malaveille C; Matullo G; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Järvholm B; Hallmans G; Day NE; Allen N; Saracci R; Kaaks R; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2118-24. PubMed ID: 16172219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
    McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
    Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation.
    Mooney LA; Santella RM; Covey L; Jeffrey AM; Bigbee W; Randall MC; Cooper TB; Ottman R; Tsai WY; Wazneh L
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):627-34. PubMed ID: 8547829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
    Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
    Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
    Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
    J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
    Coghlin J; Gann PH; Hammond SK; Skipper PL; Taghizadeh K; Paul M; Tannenbaum SR
    J Natl Cancer Inst; 1991 Feb; 83(4):274-80. PubMed ID: 1994056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
    Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
    Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
    Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
    IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biomarkers of gentotoxic risk and metabolic polymorphism].
    Pavanello S; Clonfero E
    Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice.
    Shertzer HG; Dalton TP; Talaska G; Nebert DW
    Toxicol Appl Pharmacol; 2002 May; 181(1):32-7. PubMed ID: 12030840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
    Yao L; Fang F; Wu Q; Zhong Y; Yu L
    Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.